Clinical Trials Browser

Phase 1 × Primary Myelofibrosis × arsenous acid × Clear all

NCT01014546 2022-07-22

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Phase 1 Terminated

Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis